Tadalafil Tablet, Film Coated
Product Images NDC 76420-126

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 76420-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tadalafil Figure1)

Figure (Tadalafil Figure1)
The text describes a table showing the difference in blood pressure readings (mmHg) between Tadalafil and Placebo, specifically for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure over the course of several hours.*
FDA Label Image

Figure (Tadalafil Figure2)

Figure (Tadalafil Figure2)
The text appears to be showing a table with some numerical values and characters. The values seem to be related to some medication, specifically Tadalafil and doxazosin, and their effects over time. There are also some placeholders and characters that do not provide much context. It is not clear what the purpose or source of this table is.*
FDA Label Image

Figure (Tadalafil Figure3)

FDA Label Image

Figure (Tadalafil Figure4)

Figure (Tadalafil Figure4)
This is a graph showing the plasma concentration of tadalafil (in micrograms per liter) over time (in hours) following administration of a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg doses for 5 consecutive days. It ranges from 0 to 500 micrograms per liter and from 0 to 120 hours.*
FDA Label Image

Figure 5 (Tadalafil Figure5)

Figure 5 (Tadalafil Figure5)
This text provides information on the change from baseline in IPSS (International Prostate Symptom Score) total score, comparing Tadalafil and Placebo treatments. It indicates that Tadalafil had a statistically significant improvement in the IPSS score compared to Placebo. The duration of the treatment was 4, 8, and 12 weeks.*
FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Tadalafil Tablets, Usp 5 mg (Label)

Tadalafil Tablets, Usp 5 mg (Label)
This is the label information of Tadalafil tablets, classified as Rx-only drugs with 5mg strength. It includes the drug code, lot & batch number, drug status, quantity, and the manufacturing and source details. The label also cautions against dispensing without a prescription, and suggests to keep the drug out of reach of children and stored at a specific temperature range.*
FDA Label Image

Tadalafil Tablets, Usp (Label)

Tadalafil Tablets, Usp (Label)
The text contains information about Tadalafil Tablets, USP 5mg packed and manufactured by Accord Healthcare, Inc. The tablets are yellow and diamond-shaped, and come in packs of 15, 30, 80, or 90. The drug requires a prescription, and should be stored at 20-25C. The text also includes batch and lot numbers, but they are set to 0's in this case.*
FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.